Legend
Available Timeslot
Scheduled Appointment
Personal Appointments
Request
Blocked Timeslot
Restricted Timeslot
Search Exhibitors/Products
|
AbbVie |
MGH-3-CORTEZHILL A |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
AbbVie |
MGH-3-CORTEZHILL B |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
AbbVie |
MGH-3-CORTEZHILL C |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
AbbVie |
MGH-3-HILLCREST A |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
AbbVie |
MGH-3-HILLCREST B |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
AbbVie |
MGH-3-HILLCREST C |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
AbbVie |
MGH-3-HILLCREST D |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
AbbVie |
MGH-3-TORREYHILLS A |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
AbbVie |
MGH-3-BANKERS HILL |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
AbbVie |
2105 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Acrotech Biopharma |
2301 |
|
|
|
| | | |
|
Actinium Pharmaceuticals |
2033 |
|
|
|
| | | |
|
Adaptive Biotechnologies Corporation |
3219 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
ADC Therapeutics |
MGH-2-GASLAMP A |
|
|
|
| | | |
|
ADC Therapeutics |
MM-1-OCEANSIDE |
|
|
|
| | | |
|
ADC Therapeutics |
1227 |
|
|
|
| | | |
|
Agios Pharmaceuticals |
105 |
|
|
|
| | | |
|
American Association for Cancer Research |
200 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
American Porphyria Foundation |
28 |
|
|
|
| | | |
|
American Society for Transplantation and Cellular Therapy (ASTCT) |
118 |
|
|
|
| | | |
|
American Society of Gene and Cell Therapy (ASGCT) |
37 |
|
|
|
| | | |
|
American Society of Hematology |
1215 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
American Society of Pediatric Hematology Oncology (ASPHO) |
24 |
|
|
|
| | | |
|
Amgen |
HB3 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | |
|
Amgen (Commercial) |
533 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | |
|
Amyloidosis Foundation |
12 |
|
|
|
| | | |
|
Amyloidosis Support Groups |
40 |
|
|
|
| | | |
|
Apellis Pharmaceuticals |
513 |
|
|
|
| | | |
|
Apellis Pharmaceuticals |
612 |
|
|
|
| | | |
|
Aplastic Anemia and MDS International Foundation, Inc. |
2043 |
|
|
|
| | | |
|
Applied Cells |
3246 |
|
|
|
| | | |
|
Arcellx |
1615 |
|
|
|
| | | |
|
argenx |
2705 |
|
|
|
| | | |
|
ARUP Laboratories |
413 |
|
|
|
| | | |
|
Ascentage Pharma |
3337 |
|
|
|
| | | |
|
Association for Value-Based Cancer Care |
21 |
|
|
|
| | | |
|
Association of Cancer Care Centers |
34 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Association of PAs in Oncology |
17 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Astellas Pharma US, Inc. |
2421 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | |
|
AstraZeneca |
COBALT520 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | |
|
AstraZeneca |
COBALT501C |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | |
|
AstraZeneca |
COBALT501B |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | |
|
AstraZeneca |
COBALT501A |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | |
|
AstraZeneca |
COBALT500 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | |
|
AstraZeneca |
COBALT502A |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | |
|
AstraZeneca |
COBALT502B |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | |
|
AstraZeneca |
EMB4 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | |
|
AstraZeneca |
EMB5 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | |
|
AstraZeneca |
EMB6 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | |
|
AstraZeneca |
EMB19 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | |
|
AstraZeneca |
EMB20 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | |
|
AstraZeneca |
EMB21 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | |
|
AstraZeneca |
EMB22 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | |
|
AstraZeneca |
1433 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | |
|
Bayer |
848 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | | |
|
Beam Therapeutics |
MGH-2-BALBOA C |
|
|
|
| | | |
|
Beam Therapeutics |
1449 |
|
|
|
| | | |
|
BeiGene |
EMB70 |
|
|
|
| | | |
|
BeiGene |
EMB71 |
|
|
|
| | | |
|
BeiGene |
EMB72 |
|
|
|
| | | |
|
BeiGene |
EMB73 |
|
|
|
| | | |
|
BeiGene USA, Inc. |
417 |
|
|
|
| | | |
|
Binaytara Foundation |
26 |
|
|
|
| | | |
|
Binding Site, Inc. |
2455 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
BioMarin Pharmaceutical Inc. |
1225 |
|
|
|
| | | |
|
Biomea Fusion, Inc |
221 |
|
|
|
| | | |
|
BioSkryb Genomics Inc. |
3421 |
|
|
|
| | | |
|
BioSpherix |
3302 |
|
|
|
| | | |
|
Blood Cancers Today / Mashup Media |
3146 |
|
|
|
| | | |
|
Blue Spark Technologies, Inc. |
1456 |
|
|
|
| | | |
|
bluebird bio |
HB5 |
|
|
|
| | | |
|
bluebird bio |
HB4 |
|
|
|
| | | |
|
bluebird bio |
739 |
|
|
|
| | | |
|
bluebird bio |
749 |
|
|
|
| | | |
|
Blueprint Medicines |
541 |
|
|
|
| | | |
|
BMS |
OMNI-Gallery 2 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
BMS |
OMNI-Gallery 3A |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
BMS |
OMNI-Gallery 3B |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
BMS |
OMNI-4-GASLAMP1 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
BMS |
OMNI-4-GASLAMP2 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
BMS |
OMNI-4-GASLAMP3 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
BMS |
OMNI-4-GASLAMP4 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
BMS |
OMNI-4-GASLAMP5 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
BRAZILIAN ASSOCIATION OF HEMATOLOGY, HEMOTHERAPY AND CELL THERAPY |
32 |
|
|
|
| | | |
|
Bristol Myers Squibb |
2609 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Caribou Biosciences, Inc. |
3253 |
|
|
|
| | | |
|
Catalyst Oncology |
2553 |
|
|
|
| | | |
|
Children's Hospital of Philadelphia |
3308 |
|
|
|
| | | |
|
Citius Pharmaceuticals |
3343 |
|
|
|
| | | |
|
City of Hope Comprehensive Cancer Center |
313 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Cleveland Clinic Taussig Cancer Institute |
2134 |
|
|
|
| | | |
|
CLL Society |
7 |
|
|
|
| | | |
|
Cogent Biosciences |
2804 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Conexiant |
2100 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | |
|
Cooley's Anemia Foundation |
16 |
|
|
|
| | | |
|
CRISPR Therapeutics |
1049 |
|
|
|
| | | |
|
Cryoport Systems |
512 |
|
|
|
| | | |
|
CSL Behring |
625 |
|
|
|
| | | |
|
Curis, Inc. |
2605 |
|
|
|
| | | |
|
Daiichi Sankyo |
HB11 |
|
|
|
| | | |
|
Daiichi Sankyo |
HB10 |
|
|
|
| | | |
|
Daiichi Sankyo |
133 |
|
|
|
| | | |
|
Diagenode, Inc. |
1357 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | |
|
Diamond Blackfan Anemia Canada |
9 |
|
|
|
| | | |
|
Diamond Blackfan Anemia Foundation Inc. |
10 |
|
|
|
| | | |
|
Doximity |
2102 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Editas Medicine |
136 |
|
|
|
| | | |
|
Eli Lilly and Company |
OMNI-5-BALBOA 2 |
|
|
|
| | | |
|
Eli Lilly and Company |
OMNI-5-BALBOA 1 |
|
|
|
| | | |
|
Eli Lilly and Company |
1715 |
|
|
|
| | | |
|
Emmes Company LLC |
145 |
|
|
|
| | | |
|
Enable Injections |
2348 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Eurofins Viracor |
3405 |
|
|
|
| | | |
|
European Hematology Association |
300 |
|
|
|
| | | |
|
Foresight Diagnostics |
3423 |
|
|
|
| | | |
|
Fortrea |
1956 |
|
|
|
| | | |
|
Foundation for Sickle Cell Disease Research |
2652 |
|
|
|
| | | |
|
Foundation for the Accreditation of Cellular Therapy |
5 |
|
|
|
| | | |
|
Foundation Medicine |
OMNI-6-BOARDROOM 2 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Foundation Medicine |
1348 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Galapagos |
3313 |
|
|
|
| | | |
|
Gamida Cell |
2247 |
|
|
|
| | | |
|
Gamida Cell |
2346 |
|
|
|
| | | |
|
Genentech |
HB6 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Genentech |
715 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Genmab |
3029 |
|
|
|
| | | |
|
GenScript ProBio USA Inc |
120 |
|
|
|
| | | |
|
Geron Inc. |
HB13 |
|
|
|
| | | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Geron Inc. |
2405 |
|
|
|
| | | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Gilead and Kite Oncology |
MM-1-LEUCADIA |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Gilead and Kite Oncology |
MM-1-LAGUNA |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Gilead and Kite Oncology |
EMB40 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Gilead and Kite Oncology |
EMB41 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Gilead and Kite Oncology |
EMB58 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Gilead and Kite Oncology |
EMB59 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Gilead and Kite Oncology |
1233 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
GRAIL |
2019 |
|
|
|
| | | |
|
GSK |
Presidio 2 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
GSK |
Presidio 1 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
GSK |
EMB11 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
GSK |
EMB12 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
GSK |
EMB13 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
GSK |
EMB14 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
GSK |
1015 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Haymarket Oncology |
2704 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
HCU Network America |
36 |
|
|
|
| | | |
|
HealthTree Foundation |
19 |
|
|
|
| | | |
|
HealthWell Foundation |
29 |
|
|
|
| | | |
|
Histiocyte Society/Histiocytosis Association |
38 |
|
|
|
| | | |
|
HMP Global |
3433 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Ichnos Sciences |
2940 |
|
|
|
| | | |
|
ICON plc |
2101 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Imaging Endpoints II, LLC |
2155 |
|
|
|
| | | |
|
International Myeloma Foundation |
2401 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
International Myeloma Society |
2 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | |
|
International Society on Thrombosis and Haemostasis (ISTH) |
13 |
|
|
|
| | | |
|
Intrinsic LifeSciences |
3014 |
|
|
|
| | | |
|
Ipsen Biopharmaceuticals |
EMB77 |
|
|
|
| | | |
|
Ipsen Biopharmaceuticals |
EMB78 |
|
|
|
| | | |
|
Ipsen Biopharmaceuticals |
1453 |
|
|
|
| | | |
|
IQVIA Biotech |
2148 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
JAMA Network |
301 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Jazz Pharmaceuticals |
EMB48 |
|
|
|
| | | |
|
Jazz Pharmaceuticals |
EMB51 |
|
|
|
| | | |
|
Jazz Pharmaceuticals |
2819 |
|
|
|
| | | |
|
Johnson & Johnson |
MM-3-CARDIFF/CARLSBAD |
|
|
|
| | | |
|
Johnson & Johnson |
MM-3-ENCINITAS |
|
|
|
| | | |
|
Johnson & Johnson |
MM-3-DELMAR |
|
|
|
| | | |
|
Johnson & Johnson |
MM-3-PALOMAR |
|
|
|
| | | |
|
Johnson & Johnson |
MM-3-MIRAMAR |
|
|
|
| | | |
|
Johnson & Johnson |
MM-3-MISSION HILLS |
|
|
|
| | | |
|
Johnson & Johnson |
MM-4-DANA POINT |
|
|
|
| | | |
|
Johnson & Johnson |
MM-4-LA COSTA |
|
|
|
| | | |
|
Johnson & Johnson |
MM-4-NEWPORT |
|
|
|
| | | |
|
Johnson & Johnson |
MM-4-CATALINA |
|
|
|
| | | |
|
Johnson & Johnson |
MM-4-LA JOLLA |
|
|
|
| | | |
|
Johnson & Johnson |
MM-4-CORONADO |
|
|
|
| | | |
|
Johnson & Johnson |
MM-4-MALIBU |
|
|
|
| | | |
|
Johnson & Johnson |
EMB7 |
|
|
|
| | | |
|
Johnson & Johnson |
EMB8 |
|
|
|
| | | |
|
Johnson & Johnson |
EMB9 |
|
|
|
| | | |
|
Johnson & Johnson |
EMB10 |
|
|
|
| | | |
|
Johnson & Johnson |
EMB15 |
|
|
|
| | | |
|
Johnson & Johnson |
EMB16 |
|
|
|
| | | |
|
Johnson & Johnson |
EMB17 |
|
|
|
| | | |
|
Johnson & Johnson |
EMB18 |
|
|
|
| | | |
|
Johnson & Johnson -Advocacy |
EMB39 |
|
|
|
| | | |
|
Johnson & Johnson -Advocacy |
EMB60 |
|
|
|
| | | |
|
Johnson & Johnson Innovative Medicine |
2129 |
|
|
|
| | | |
|
Karyopharm Therapeutics Inc. |
733 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Kura Oncology |
2701 |
|
|
|
| | | |
|
Labcorp Oncology |
455 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Legend Biotech |
2805 |
|
|
|
| | | |
|
Machaon Diagnostics, Inc. |
449 |
|
|
|
| | | |
|
Mallinckrodt Pharmaceuticals |
3441 |
|
|
|
| | | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Mayo Clinic Laboratories |
2017 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
MDoutlook |
1249 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Mechatronics Instruments B.V. |
951 |
|
|
|
| | | |
|
Med Learning Group |
2253 |
|
|
|
| | | |
|
Med Learning Group |
3055 |
|
|
|
| | | |
|
Medidata, a Dassault Systèmes company |
1055 |
|
|
|
| | | |
|
Medpace Inc. |
104 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | | |
|
Medscape Oncology & Hematology |
1325 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Melinta Therapeutics |
1857 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Menarini Silicon Biosystems |
2515 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | |
|
Merck & Co., Inc |
MGH-2-GASLAMP B |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Merck & Co., Inc |
MGH-2-GASLAMP C |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Merck & Co., Inc |
MGH-2-GASLAMP D |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Merck & Co., Inc |
MGH-2-LAJOLLA A |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Merck & Co., Inc |
MGH-2-LAJOLLA B |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Merck & Co., Inc |
MGH-2-OLDTOWN A |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Merck & Co., Inc |
MGH-2-OLDTOWN B |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Merck & Co., Inc |
432 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Miltenyi Biotec |
553 |
|
|
|
| | | |
|
Mission Bio |
2112 |
|
|
|
| | | |
|
MJH Life Sciences |
649 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Moffitt Cancer Center |
349 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | |
|
National Blood Clot Alliance |
8 |
|
|
|
| | | |
|
National Comprehensive Cancer Network (NCCN) |
11 |
|
|
|
| | | |
|
National Heart, Lung, and Blood Institute |
2901 |
|
|
|
| | | |
|
NMDP |
112 |
|
|
|
| | | |
|
Northside Hospital |
949 |
|
|
|
| | | |
|
Notable Labs |
2554 |
|
|
|
| | | |
|
Novartis |
Torrey Pines 2 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Novartis |
Torrey Pines 3 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Novartis |
MM-L/2-Torrey Pines 1 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Novartis |
EMB23 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Novartis |
2529 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Novo Nordisk Healthcare AG |
EMB36 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Novo Nordisk Healthcare AG |
1748 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
NURIX |
655 |
|
|
|
| | | |
|
Omeros Corporation |
321 |
|
|
|
| | | |
|
Ossium Health, Inc. |
217 |
|
|
|
| | | |
|
Parexel |
126 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Pfizer |
HB2 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Pfizer |
HB1 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Pfizer |
EMB1 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Pfizer |
EMB2 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Pfizer |
EMB3 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Pfizer |
EMB24 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Pfizer |
833 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
PharmaEssentia Corporation |
3229 |
|
|
|
| | | |
|
Platelet Disorder Support Association |
4 |
|
|
|
| | | |
|
PlatformQ Health |
2456 |
|
|
|
| | | |
|
Precision for Medicine |
2021 |
|
|
|
| | | |
|
Premier Research |
2500 |
|
|
|
| | | |
|
Protagonist Therapeutics, Inc |
1549 |
|
|
|
| | | |
|
PSI CRO |
2037 |
|
|
|
| | | |
|
Q2 Solutions |
2249 |
|
|
|
| | | |
|
Rapid Novor Inc. |
2841 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Rigel Pharmaceuticals |
3005 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Roswell Park Comprehensive Cancer Center |
3417 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Sanguina, Inc. |
3214 |
|
|
|
| | | |
|
Sanofi |
MM-1-SANTA ROSA |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Sanofi |
EMB26 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Sanofi |
EMB27 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Sanofi |
EMB28 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Sanofi |
EMB29 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Sanofi |
EMB30 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Sanofi |
EMB31 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Sanofi |
EMB32 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Sanofi |
EMB33 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Sanofi |
EMB34 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Sanofi |
EMB35 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Sanofi |
1415 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Sarah Cannon Research Institute |
1154 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Saudi Society of Blood & Marrow Transplantation (SSBMT) |
25 |
|
|
|
| | | |
|
Sebia |
3209 |
|
|
|
| | | |
|
Secura Bio Inc. |
1849 |
|
|
|
| | | |
|
Shwachman-Diamond Syndrome Foundation |
14 |
|
|
|
| | | |
|
Silence Therapeutics |
3241 |
|
|
|
| | | |
|
Sobi, Inc. |
2429 |
|
|
|
| | | |
|
Society for Immunotherapy of Cancer (SITC) |
18 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Society of Hematologic Oncology |
35 |
|
|
|
| | | |
|
Spark Therapeutics, Inc. |
849 |
|
|
|
| | | |
|
St. Jude Children's Research Hospital |
39 |
|
|
|
| | | |
|
Star Therapeutics |
108 |
|
|
|
| | | |
|
Sumitomo Pharma America |
3305 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Sutter Health – Bay Area |
3336 |
|
|
|
| | | |
|
Syndax Pharmaceuticals, Inc. |
OMNI-5-BALBOA 3 |
|
|
|
| | | |
|
Syndax Pharmaceuticals, Inc. |
3019 |
|
|
|
| | | |
|
Syneos Health |
1149 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Syros |
3200 |
|
|
|
| | | |
|
Taiho Oncology - Commercial |
615 |
|
|
|
| | | |
|
Taiho Oncology, Inc. |
305 |
|
|
|
| | | |
|
Takeda |
OMNI-Gallery 1 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Takeda |
EMB55 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Takeda |
EMB56 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Takeda |
EMB57 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Takeda |
2829 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Takeda Pharmaceuticals |
EMB42 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Takeda Pharmaceuticals |
EMB43 |
|
|
|
| | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Team Telomere |
6 |
|
|
|
| | | |
|
Telo Genomics |
400 |
|
|
|
| | | |
|
The Japanese Society of Hematology |
1 |
|
|
|
| | | |
|
The MDS Foundation, Inc. |
3 |
|
|
|
| | | |
|
Theradex Oncology |
755 |
|
|
|
| | | |
|
ThermoFisher |
2505 |
|
|
|
| | | |
|
Turkish Society of Hematology |
41 |
|
|
|
| | | |
|
TwinStrand Biosciences |
1548 |
|
|
|
| | | |
|
UC San Diego Hemophilia and Thrombosis Treatment Center |
3338 |
|
|
|
| | | |
|
UCI Health |
20 |
|
|
|
| | | |
|
United Porphyrias Association |
22 |
|
|
|
| | | |
|
Vaniam Group |
1155 |
|
|
|
| | | |
|
Vertex Pharmaceuticals Inc. |
EMB49 |
|
|
|
| | | |
|
Vertex Pharmaceuticals Inc. |
EMB50 |
|
|
|
| | | |
|
Vertex Pharmaceuticals Inc. |
504 |
|
|
|
| | | |
|
Veterans Health Administration |
3431 |
|
|
|
| | | |
|
Viracta Therapeutics |
3147 |
|
|
|
| | | |
|
Voiant |
2015 |
|
|
|
| | | |
|
Wolters Kluwer |
2915 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | ![Twitter Twitter](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField19.png) | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Worldwide Clinical Trials |
3105 |
|
|
|
| ![Facebook Facebook](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField20.png) | | ![LinkedIn LinkedIn](imgHandler.ashx?Task=1&ID=../CUSTOM/CustomField21.png) |
|
Wuhan Kindstar Medical Laboratory Limited Company |
142 |
|
|
|
| | | |
|
X4 Pharmaceuticals |
2106 |
|
|
|
| | | |